All terms in GO

Label Id Description
paramesonephric duct development GO_0061205 [The process whose specific outcome is the progression of the paramesonephric duct over time, from its formation to the mature structure. Mullerian ducts (or paramesonephric ducts) are paired ducts of the embryo that run down the lateral sides of the urogenital ridge and terminate at the mullerian eminence in the primitive urogenital sinus. In the female, they will develop to form the fallopian tubes, uterus, cervix, and the upper portion of the vagina; in the male, they are lost. These ducts are made of tissue of mesodermal origin.]
11-deoxycorticosterone binding GO_1903878 [Binding to 11-deoxycorticosterone.]
21-deoxycortisol binding GO_1903877 [Binding to 21-deoxycortisol.]
7-methylguanosine cap hypermethylation GO_0036261 [Hypermethylation of the 7-(mono)methylguanosine (m(7)G) cap structure at the 2' position of the guanosine residue to convert a mono-methylated cap to a 2,2,7-trimethylguanosine cap structure. This type of cap modification occurs on small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs) and is dependent on prior guanine-N7 methylation.]
positive regulation of gastric emptying GO_0120062 [Any process that increases the frequency, rate or extent of any gastric emptying process, the process in which the liquid and liquid-suspended solid contents of the stomach exit through the pylorus into the duodenum.]
regulation of gastric emptying GO_0120060 [Any process that modulates the frequency, rate or extent of any gastric emptying process, the process in which the liquid and liquid-suspended solid contents of the stomach exit through the pylorus into the duodenum.]
11beta-hydroxyprogesterone binding GO_1903879 [Binding to 11beta-hydroxyprogesterone.]
negative regulation of gastric emptying GO_0120061 [Any process that decreases the frequency, rate or extent of any gastric emptying process, the process in which the liquid and liquid-suspended solid contents of the stomach exit through the pylorus into the duodenum.]
mitochondrial depolarization GO_0051882 [The process in which the potential difference across the mitochondrial membrane is reduced from its steady state level.]
GO_0036264 GO_0036264
GO_0036263 GO_0036263
granulysin production GO_0036262 [The appearance of granulysin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]
positive regulation of timing of exogen GO_0051888 [Any process that activates or increases the frequency, rate or extent of timing of exogen, the shedding phase of the hair cycle.]
regulation of timing of exogen GO_0051887 [Any process that modulates the frequency, rate or extent of timing of exogen, the shedding phase of the hair cycle.]
negative regulation of timing of exogen GO_0051889 [Any process that stops, prevents, or reduces the frequency, rate or extent of timing of exogen, the shedding phase of the hair cycle.]
regulation of timing of anagen GO_0051884 [Any process that modulates the frequency, rate or extent of timing of anagen, the growth phase of the hair cycle.]
obsolete killing of cells in other organism involved in symbiotic interaction GO_0051883 [OBSOLETE. Any process mediated by an organism that results in the death of cells in a second organism, where the two organisms are in a symbiotic interaction.]
negative regulation of timing of anagen GO_0051886 [Any process that stops, prevents, or reduces the frequency, rate or extent of timing of anagen, the growth phase of the hair cycle.]
positive regulation of timing of anagen GO_0051885 [Any process that activates or increases the frequency, rate or extent of timing of anagen, the growth phase of the hair cycle.]
17alpha-hydroxyprogesterone binding GO_1903880 [Binding to 17alpha-hydroxyprogesterone.]